Efficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma
Clinical trial NCT07091227 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07091227
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-20
- Primary completion
- 2026-07-20
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.